Does Nicotine Affect Gout and Uric Acid Levels?

Nicotine raises uric acid levels through at least one well-studied enzyme pathway, yet the broader relationship between tobacco use, uric acid, and gout is surprisingly contradictory. Some large studies find that male smokers actually have lower uric acid and fewer gout diagnoses than nonsmokers, while other studies find the opposite in women and in users of newer nicotine products like e-cigarettes. The picture changes again after someone quits smoking. What emerges is not a clean answer but a set of findings that depend heavily on sex, the type of nicotine product, and how long someone has been using it.

The Smoking and Gout Paradox

If you looked only at certain well-known cohort studies, you might conclude that smoking protects against gout. Data from the Framingham Heart Study found that smokers developed gout at a lower rate than nonsmokers, with about a quarter lower risk overall and about a third lower risk among men specifically.¹ A separate prospective study confirmed that current male smokers had lower circulating urate than former or never smokers.² A Japanese study of men found that current smokers had the lowest average uric acid at about 5.98 mg/dL, compared to 6.10 in never-smokers and 6.18 in ex-smokers.³

But that apparent protection falls apart quickly once you look beyond men in traditional cigarette studies. A large Korean national health survey found no meaningful link between smoking and uric acid in men at all, while female current smokers had significantly higher uric acid and were roughly 50% more likely to have hyperuricemia compared to women who never smoked.⁴ That same survey dataset, analyzed in a different study, found that the odds of doctor-diagnosed gout in female current smokers were dramatically elevated compared to female never-smokers.⁵ These are not small discrepancies. The data genuinely point in opposite directions depending on the population studied.

Why the Effects Split So Sharply by Sex

The sex difference is one of the most consistent findings across studies, and it is large enough that talking about “smoking and uric acid” without specifying sex borders on meaningless. In men, the few studies that do show an association between smoking and lower uric acid tend to find effects of only a few hundredths of a milligram per deciliter, and some find no significant effect at all. The Korean data are a good example: male uric acid levels barely budged across smoking categories, and no statistical association emerged.⁴ The Framingham data did find a meaningful reduction in gout incidence in men, but that reduction was not clearly driven by lower uric acid alone.¹

In women, the pattern is more consistently unfavorable. Female current smokers in the Korean analyses had uric acid levels roughly 0.3 to 0.4 mg/dL higher than never-smokers, and the odds of hyperuricemia and gout both climbed.⁵ In the Framingham data, the apparent protective effect of smoking against gout disappeared entirely in women, with the hazard ratio sitting close to 1.0.¹

Why the split? Researchers have not fully answered this, but estrogen may play a role. Estrogen promotes uric acid excretion through the kidneys, which is one reason premenopausal women have lower uric acid than men. If smoking disrupts estrogen levels or kidney handling of urate differently in women, it could explain why cigarettes push female uric acid up while having a more ambiguous effect in men. Animal research supports the idea that nicotine’s impact on uric acid is sex-dependent: a rat study found that nicotine raised uric acid more in females than males, with female groups showing significantly higher levels than their male counterparts at the same doses.⁶

How Nicotine Raises Uric Acid at the Enzyme Level

When you separate nicotine itself from all the other chemicals in cigarette smoke, the picture becomes clearer. Nicotine increases the activity of xanthine oxidase, the enzyme responsible for converting purines into uric acid in the liver. An animal study found that nicotine exposure raised both xanthine oxidase and adenosine deaminase activity and led to higher uric acid in both the blood and liver tissue.⁷ Xanthine oxidase is the same enzyme targeted by drugs like allopurinol and febuxostat, two of the most common gout medications. By pushing this enzyme to work harder, nicotine essentially accelerates uric acid production.

This creates an interesting contradiction with the human epidemiological data showing that some male smokers have lower uric acid. Cigarette smoke contains thousands of compounds beyond nicotine, including carbon monoxide and hydrogen cyanide, which bind hemoglobin and alter kidney blood flow. It is possible that these other components affect how the kidneys filter and excrete uric acid, partially offsetting or masking nicotine’s uric-acid-raising effect. A study of smokers found a negative correlation between uric acid and urinary cotinine (a nicotine metabolite) within the smoking group itself, suggesting that among people who already smoke, those with the highest nicotine exposure may handle uric acid differently.⁸ The interaction between nicotine’s enzyme effects and the rest of the smoke package is likely why the epidemiology looks so messy.

What Nicotine Does to Gout Inflammation

Uric acid levels are only half the story in gout. The other half is the inflammatory flare itself, the sudden, intense joint pain that happens when urate crystals trigger an immune response. Nicotine interacts with a receptor called α7nAChR, which sits on immune cells. When that receptor is activated, it dials down the production of inflammatory signals like IL-1β and TNF-α, both of which are central to a gout attack. Research using vagus nerve stimulation in mice with gouty inflammation showed that blocking this receptor eliminated the anti-inflammatory benefit, implicating the same pathway that nicotine stimulates.⁹

This anti-inflammatory mechanism could help explain the Framingham finding that male smokers got gout less often even when the uric acid difference between groups was modest. If nicotine suppresses the inflammatory cascade that turns urate crystals into a painful flare, a smoker with borderline-high uric acid might never trigger a clinical gout attack, while a nonsmoker at the same uric acid level does. This would show up in the data as “lower gout incidence in smokers” without a proportional drop in uric acid, which is roughly what the Framingham researchers observed.

E-Cigarettes and Dual Use

If cigarette smoke’s non-nicotine components were partly responsible for keeping uric acid in check, then products that deliver nicotine without combustion should make things worse. The data support this. A Korean study found that current e-cigarette users had the highest uric acid levels of any group, and the prevalence of hyperuricemia in current e-cigarette users was roughly two and a half times that of never-users.¹⁰ People who used both e-cigarettes and conventional cigarettes (dual users) had nearly double the odds of hyperuricemia compared to those who used neither.¹⁰

A separate study found that after adjusting for other risk factors, e-cigarette use was associated with an odds ratio of about 2.67 for hyperuricemia compared to non-use.¹¹ E-cigarettes also raised C-reactive protein, a marker of systemic inflammation, which may compound the gout risk beyond what uric acid alone would predict. If you are someone with gout who switched from cigarettes to vaping thinking it would be a metabolic wash, the evidence so far says it is not. E-cigarettes appear to deliver the uric-acid-raising effects of nicotine without whatever countervailing effects combustion byproducts provide.

The same pattern holds for another form of non-combustion tobacco. A study of men using smokeless tobacco products found that gutkha consumers had significantly higher uric acid levels compared to non-users.¹² This is consistent with the idea that nicotine itself pushes uric acid up and that the combustion-related chemicals in cigarettes may be doing something separate.

The Uric Acid Rebound After Quitting

One of the more counterintuitive findings in this area is that uric acid goes up when you stop smoking. A classic study from the 1980s reported that quitting cigarettes was associated with a uric acid increase of about 0.2 to 0.5 mg/dL.¹³ This was confirmed in the Japanese study mentioned earlier, which found that after adjusting for body weight and alcohol intake, ex-smokers still had uric acid about 0.2 mg/dL higher than current smokers.³

For someone with gout, this timing matters. Quitting smoking is obviously the right health decision for dozens of other reasons, but if you are prone to gout, your doctor should know that the first months after quitting could bring a bump in uric acid. Weight gain after smoking cessation, which is common, can amplify this further, since body mass is one of the strongest predictors of uric acid levels. None of this is a reason to keep smoking. It is a reason to have your uric acid monitored during the transition and to discuss whether your gout medication needs adjusting.

Cotinine, Nicotine’s Metabolite, as a Direct Marker

Most human studies rely on self-reported smoking status, which introduces all kinds of noise. A more precise approach is to measure cotinine, the primary metabolite of nicotine, directly in the blood. When researchers did this in a study of American adolescents, they found that higher cotinine levels were associated with higher odds of hyperuricemia even after adjusting for other risk factors. Each tenfold increase in blood cotinine corresponded to about a 7% increase in the odds of elevated uric acid in the fully adjusted model.¹⁴ This adolescent finding is notable because it comes from a population that largely has not been smoking for decades, stripping away the confounding of long-term metabolic changes that make adult studies hard to interpret.

The cotinine data fit neatly with the animal evidence showing that nicotine raises xanthine oxidase activity: when you measure actual nicotine exposure in the body rather than asking people whether they smoke, the link with higher uric acid is clear and consistent. The contradiction with those earlier studies showing lower uric acid in male smokers may come down to the complexity of cigarette smoke itself and the difficulty of separating nicotine’s effect from everything else a cigarette delivers.

Smoking and the Response to Gout Medication

Here is a finding that surprises most people, including many clinicians: in gout patients already taking urate-lowering drugs, smokers were more likely to reach their target uric acid level than nonsmokers. A Thai cohort study of patients on febuxostat or allopurinol found that smokers had roughly double the odds of hitting the treatment target.¹⁵ This seems paradoxical but may be explained by the same mechanism noted earlier. Both febuxostat and allopurinol work by inhibiting xanthine oxidase. If smoking modestly suppresses uric acid through non-nicotine pathways (kidney handling, metabolic rate, appetite suppression reducing purine intake), that effect could stack on top of the drug’s action, making the medication more effective. This is a single-study observation in one cohort, so it is not something to build clinical strategy around, but it adds to the picture of smoking’s complex interactions with uric acid metabolism.

Dual Users Face the Worst Odds

Across the literature, one group consistently comes out worst: people who use both conventional cigarettes and another nicotine product simultaneously. A Chinese cross-sectional study found that male dual smokers (those using both cigarettes and another tobacco form) had about 43% higher odds of elevated uric acid compared to male non-smokers, and among those with more than 20 pack-years of exposure, the odds climbed to about 84% higher.¹⁶ The Korean e-cigarette data similarly showed that dual users (cigarettes plus e-cigarettes) had the highest hyperuricemia risk of any category studied.¹⁰

The likely explanation is straightforward: dual use means more total nicotine exposure plus all the other chemicals in combusted tobacco. You get the xanthine oxidase stimulation from high nicotine loads without enough of whatever counterbalancing mechanism combustion byproducts provide at lower smoking levels. If you have gout or hyperuricemia and are trying to transition off cigarettes, the worst strategy from a uric acid standpoint is to add e-cigarettes on top of cigarettes rather than switching fully.

Putting the Contradictions in Perspective

The research on nicotine, smoking, and uric acid is genuinely contradictory, but it becomes less confusing once you recognize that “smoking” is not the same thing as “nicotine.” Cigarette smoke is a stew of chemicals with competing metabolic effects. Nicotine itself pushes uric acid production up through xanthine oxidase. Other combustion byproducts may push kidney excretion of urate up, push appetite and body weight down, or alter blood chemistry in ways that partially mask nicotine’s effect. The net result in any given person depends on their sex, which products they use, how much they use, and what else is going on metabolically.

For practical purposes, the evidence does not support the idea that nicotine in any form is helpful for gout, despite the older Framingham finding about reduced gout incidence in male smokers. The e-cigarette data, the cotinine data in adolescents, the animal work, and the female-specific findings all point toward nicotine raising uric acid when its effects can be isolated. The apparent protection seen in male smokers likely reflects something about combustion chemistry rather than nicotine itself, and that protection does not extend to women, dual users, vapers, or smokeless tobacco users. If you have gout and are trying to manage your uric acid, nicotine products are working against you at the enzyme level, even if the overall smoke package has more complicated effects in certain populations.

1
Rheumatology. Cigarette smoking is associated with a reduction in the risk of incident gout: results from the Framingham Heart Study original cohort
2
PubMed Central. Cigarette Smoking and the Risk of Incident Gout in a Prospective Cohort Study
3
PubMed Central. Increased levels of serum uric acid among ex-smokers
4
PubMed Central. Association between smoking and serum uric acid in Korean population
5
Tobacco Induced Diseases. Association of smoking with serum uric acid levels, hyperuricemia, and gout based on the 7th to 9th Korea National Health and Nutrition Examination Survey
6
Toxicology Reports. Sub-acute administration of lower doses of nicotine caused sex-dependent improvement of renal function in Wistar rats
7
PubMed. Sodium acetate protects against nicotine-induced excess hepatic lipid in male rats by suppressing xanthine oxidase activity
8
PubMed Central. Effect of cigarette smoking on plasma uric acid concentrations
9
Scientific Reports. Transcutaneous auricular vagus nerve stimulation mitigates gouty inflammation by reducing neutrophil infiltration in BALB/c mice
10
PubMed Central. Association of electronic cigarette exposure with serum uric acid level and hyperuricemia: 2016-2017 Korea National Health and Nutritional Examination Survey
11
PubMed. Association Between Electronic Cigarette Use and Levels of High-Sensitivity C-Reactive Protein and Uric Acid
12
Journal of Analytical & Pharmaceutical Research. Chronic smokeless tobacco consumption contributes to the development of renal diseases in the human male volunteers
13
PubMed. Changes after quitting cigarette smoking
14
PubMed Central. Association of Serum Cotinine with Hyperuricemia in American Adolescents: A Cross-Sectional Study
15
SpringerLink / Clinical Rheumatology. Efficacy of febuxostat versus allopurinol and the predictors of achieving target serum urate in a cohort of Thai people with gout
16
PubMed Central. Association between smoking behavior and serum uric acid among the adults: Findings from a national cross-sectional study